XSOLIS

Nashville, United States Founded: 2013 • Age: 13 yrs
AI-based platform for physicians and payers to analyze denial management
Annual revenue - Latest available
Total funding $75.0M 2 rounds
Employees 166 Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 8 Brand Intelligence

About XSOLIS

XSOLIS is a company based in Nashville (United States) founded in 2013. XSOLIS has raised $75 million across 2 funding rounds from investors including Brighton Park Capital. The company has 166 employees as of December 31, 2022. XSOLIS has completed 1 acquisition, including MEDarchon. XSOLIS offers products and services including Dragonfly Platform, Physician Advisor Services, and Denial Services. XSOLIS operates in a competitive market with competitors including Infinx, AKASA, Plusgrade, R1 RCM and RateGain, among others.

  • Headquarter Nashville, United States
  • Employees 166 as on 31 Dec, 2022
  • Sectors
    Healthcare
    Technology
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Technology → Marketing, Adtech & Commerce Technology Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $75 M (USD)

    in 2 rounds

  • Latest Funding Round
    $75 M (USD), Series C

    Jun 28, 2021

  • Investors
  • Employee Count
    166

    as on Dec 31, 2022

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of XSOLIS

XSOLIS offers a comprehensive portfolio of products and services, including Dragonfly Platform, Physician Advisor Services, and Denial Services.

Product name locked
Category locked
Primary

Provides real-time analytics for patient care and utilization review.

Product name locked
Category locked
Locked

Supplements staff with AI-driven clinical advice and coverage.

Product name locked
Category locked
Locked

Manages appeals and documentation for revenue optimization.

People of XSOLIS

Headcount 50-200
Employee Profiles 97
Employee Profiles
People
Zach Evans
Chief Technology Officer
People
Caleb Y.
Enterprise Sales
People
Brent Teveit
Chief Data Science Officer
People
Heather Bassett
Chief Medical Officer

Unlock access to complete

Funding Insights of XSOLIS

XSOLIS has successfully raised a total of $75M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in XSOLIS

XSOLIS has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Brighton Park Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
Brighton Park Capital is focused on growth equity investments.
Locked Locked Locked
Premium access

Investor details for XSOLIS

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by XSOLIS

XSOLIS has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MEDarchon.

Investments
Premium access

Investment portfolio details for XSOLIS

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Mobile-based care coordination system for hospitals and clinics along with analytics to predict patients at risk.
Locked Locked 2012 Locked
Premium access

Complete acquisition details for XSOLIS

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - XSOLIS

Premium access

Detailed financials for XSOLIS

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Xsolis Comparisons

XSOLIS Primary company
Description
AI-based platform for physicians and payers to analyze denia...
Location
Nashville, United States
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
166
As of 2022
Premium access

Peer comparison for XSOLIS

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of XSOLIS

XSOLIS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Infinx, AKASA, Plusgrade, R1 RCM and RateGain, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Revenue cycle management platform for healthcare is provided.
Locked Locked Locked
Revenue cycle automation platforms are provided for healthcare reimbursement.
Locked Locked Locked
SaaS revenue management solutions are offered to airlines for optimization.
Locked Locked Locked
End-to-end revenue cycle management is provided for healthcare organizations.
Locked Locked Locked
SaaS solutions for hospitality revenue and operations management are delivered.
Locked Locked Locked
AI-enabled inventory optimization and e-commerce solutions for airlines are provided.
Premium access

Detailed competitors of XSOLIS

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Xsolis

Premium access

Complete news archive for XSOLIS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about XSOLIS

XSOLIS was founded in 2013 and raised its 1st funding round 5 years after it was founded.

XSOLIS is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.

Joan Butters is the current CEO of XSOLIS.

XSOLIS is a funded company, having raised a total of $75M across 2 funding rounds to date.

As of Dec 31, 2022, the latest employee count at XSOLIS is 166.

XSOLIS was founded in 2013 and is headquartered in Nashville, United States. An AI-based platform is offered to physicians and payers in the healthcare sector for managing claim denials. Operations focus on analyzing potential denials during claims processing to support efficient resolution. Services include tools for identifying and addressing denial risks across payer interactions.

XSOLIS's top competitors include R1 RCM, AKASA and Volantio.

XSOLIS offers Dragonfly Platform, Physician Advisor Services, and Denial Services.

XSOLIS has made 1 acquisition, including MEDarchon.

XSOLIS has 1 investor. Key investors include Brighton Park Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available